Business Context and Reporting Period
This Form 6-K filing by Bon Natural Life Ltd (a foreign private issuer) covers the month of June 2025, with the report dated June 16, 2025. The filing discloses a material event: a new supply agreement entered into by the company's subsidiary, Xi'an App-Chem Bio (Tech) Co., Ltd ("App-Chem").
Key Financial Metrics
The filing does not provide standard financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics for the reporting period. The only specific financial figure disclosed relates to the new agreement:
- Guaranteed Aggregate Sales: Approximately US$18 million over the 36-month term of the agreement.
Material Changes and New Agreements
On May 26, 2025, App-Chem entered into a Sale Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd. ("Merrill-Youli"). Key terms include:
- Scope: Non-exclusive right for Merrill-Youli to market, distribute, and sell App-Chem's Ambroxide products in the Asia-Pacific Region.
- Term: 36 months.
- Responsibilities: App-Chem handles R&D, production, quality control, and transportation insurance. Merrill-Youli is responsible for specialized packaging costs and warehouse charges.
- Payment Terms: Full payment must be received by App-Chem prior to product dispatch.
- Quality Disputes: Claims must be submitted within two months of receipt. Re-inspection by a third party is required for discrepancies; App-Chem bears costs only if non-conformity is confirmed.
- Termination: Liquidated damages of 15% of the total agreement amount apply for unjustified termination or failure to fulfill obligations.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance or general outlook commentary beyond the specific agreement details. Identified risks and contingencies include:
- Performance Risk: The US$18 million sales figure is a guarantee, not a realized revenue figure; actual performance depends on Merrill-Youli's ability to meet the target.
- Operational Risk: App-Chem retains liability for quality issues confirmed by third-party re-inspection, though it is not liable for issues arising from improper storage or handling by the distributor.
- Legal Jurisdiction: Any lawsuits arising from the agreement must be filed in courts located in the People's Republic of China.
Investor Verification Checklist
- Verify the creditworthiness and distribution capabilities of Tianjin Merrill-Youli Trading Co., Ltd.
- Confirm the current market demand for Ambroxide products in the Asia-Pacific Region to assess the feasibility of the US$18 million sales guarantee.
- Review the full text of the Sales Distribution Agreement (Exhibit 10.1) for additional covenants not summarized in this filing.
- Monitor future filings for actual revenue recognition related to this agreement, noting the requirement for pre-dispatch payment.